Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis.
Facciorusso A, Di Maso M, Muscatiello N. Facciorusso A, et al. Dig Liver Dis. 2016 Jun;48(6):571-7. doi: 10.1016/j.dld.2016.02.005. Epub 2016 Feb 21. Dig Liver Dis. 2016. PMID: 26965785 Review.
BACKGROUND: Despite the promising results of earlier studies, a clear superiority of drug-eluting beads transarterial chemoembolization over conventional chemoembolization in unresectable hepatocellular carcinoma pati …
BACKGROUND: Despite the promising results of earlier studies, a clear superiority of drug-eluting beads transarterial …
Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
Yang B, Liang J, Qu Z, Yang F, Liao Z, Gou H. Yang B, et al. PLoS One. 2020 Feb 19;15(2):e0227475. doi: 10.1371/journal.pone.0227475. eCollection 2020. PLoS One. 2020. PMID: 32074102 Free PMC article.
Conventional transarterial chemoembolization (cTACE), drug-eluting beads (DEB-TACE) and transarterial radioembolization (TARE) are alternative strategies for unresectable hepatocellular carcinoma (HCC). However, which of the
Conventional transarterial chemoembolization (cTACE), drug-eluting beads (DEB-TACE) and transarterial rad
Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Chen P, Yuan P, Chen B, Sun J, Shen H, Qian Y. Chen P, et al. Clin Res Hepatol Gastroenterol. 2017 Feb;41(1):75-85. doi: 10.1016/j.clinre.2016.05.013. Epub 2016 Jun 24. Clin Res Hepatol Gastroenterol. 2017. PMID: 27350573 Review.
BACKGROUND AND OBJECTIVES: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for unresectable hepatocellular carcinoma (HCC). It consists of conventional TACE (cTACE) and drug-eluting beads T …
BACKGROUND AND OBJECTIVES: Transcatheter arterial chemoembolization (TACE) is the first-line treatment for unresectable